Clinical Trials Directory

Trials / Completed

CompletedNCT05809882

Study of Experience of High-frequency Repetitive Transcranial

High-frequency rTMS Therapy Experience

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Rongjun Hospital of Hebei Province Affiliated to North China University of Science and Technology · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Objective: To understand the personal experience of schizophrenia patients following repetitive transcranial magnetic stimulation (rTMS) and its connection with changes in mental symptoms, thereby enhancing the overall understanding of TMS. Method: The investigators selected eligible schizophrenia patients for fixed-parameter rTMS treatment. A self-experience checklist post-TMS treatment and positive and negative symptom scales (PANSS) were applied to evaluate the treatment.

Detailed description

The investigators recruited male subjects admitted to who met the criteria. They were divided into a control and a treatment group. A double-blind approach was adopted. The subjects were unaware of whether real/pseudo stimulation was applied, and the evaluators did not know the grouping specifics. All of the enrolled cases were tested for stimulation thresholds in the bilateral prefrontal cortex. The TMS treatment device was a Magstim RAPID2 neuromagnetic stimulator (Magstim) with an "8"-type coil. The study group was administered real stimulation. The treatment parameters were as follows: frequency range, 20 Hz; 90% motion threshold; 3 s of stimulation; a 57 s interval; 15 min of stimulation for each side, five times per week for a total of 20 times. For the control group, a 60% motion threshold was set; the remaining parameters were consistent with the study group but with no stimulating energy output. The therapeutic instrument model, appearance, operation process, and sounds when effecting treatment were the same for both groups. A self-experience checklist post-TMS treatment and positive and negative symptom scales (PANSS) were applied to evaluate the treatment.

Conditions

Interventions

TypeNameDescription
DEVICEMagstim RAPID2 neuromagnetic stimulator (Magstim) with an "8"-type coilfrequency range, 20 Hz; 90% motion threshold; 3 s of stimulation; a 57 s interval; 15 min of stimulation for each side, five times per week for a total of 20 times
DEVICEMagstim RAPID2 neuromagnetic stimulator (Magstim) with an "8"-type coilfrequency range, 20 Hz,60% motion threshold; 3 s of stimulation; a 57 s interval; 15 min of stimulation for each side, five times per week for a total of 20 times. But with no stimulating energy output.

Timeline

Start date
2019-03-01
Primary completion
2020-01-31
Completion
2020-02-20
First posted
2023-04-12
Last updated
2023-04-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05809882. Inclusion in this directory is not an endorsement.